Perifect ^{For Profit}

Perifect engages in the development of medical devices for the treatment of cardiac conditions and pericardial therapies. The company's first product The PeriCardioScope provides a means for convenient and safe access to the pericardial space by a sub-xiphoid approach. Its use will drive the market for pericardial access base procedures such as VT ablation, epicardial ablation, lead placement and removal, left atrial appendage ligation, pericardiocentesis, and drug delivery. The device combines two main features of video-based navigation to the pericardium without harming adjacent organs and a suction mechanism for safe penetration into the pericardial space. Both of these elements are key to successful access into the pericardial space. Perifect was founded in 2010 and is headquartered in Herzliya, Israel.